Company / Free Cash Flow
Thermo Fisher Scientific Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$6.3B
FY2025
5-year range
$4.0B / $7.3B
FY2021-FY2025
Trend
-13.4%
vs FY2024
Sector context
#5 of 151
Health Care
What the data says
Among 151 Health Care companies, Thermo Fisher Scientific is in the top 3% for free cash flow. Free Cash Flow has fluctuated over the past 10 years, ranging from $2.8B in FY2016 to $7.3B in FY2024.
Based on SEC 10-K filings.
$6.3B in FY2025 with a 5-year CAGR of -1.6%. Top quartile in the Health Care sector.
Declined from $6.8B to $6.3B over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -2.6%
- 5-Year CAGR
- -1.6%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 151This company $6.3B Sector average $779.8M
▼
+707.0% above sector average
Key checks
Key Insights
- 5-year CAGR of -1.6%, indicating a declining trend.
- In FY2025, free cash flow decreased 13.4% year-over-year.
- Ranks #5 out of 151 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2024.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.3B | -13.4% |
| FY2024 | $7.3B | +7.0% |
| FY2023 | $6.8B | -0.4% |
| FY2022 | $6.8B | +68.4% |
| FY2021 | $4.0B | -40.6% |
| FY2020 | $6.8B | +68.4% |
| FY2019 | $4.0B | +6.9% |
| FY2018 | $3.8B | +8.2% |
| FY2017 | $3.5B | +24.3% |
| FY2016 | $2.8B | +11.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026